| Dermatitis |
1 |
1 |
| Atopic Dermatitis |
0 |
1 |
| Otolaryngology |
0 |
0.57 |
| Global Warming |
0 |
0.47 |
| Asthma |
0 |
0.37 |
| Eczema |
0 |
0.34 |
| Pruritus |
0 |
0.34 |
| Allergic Rhinitis |
0 |
0.3 |
| Biologic Therapy |
0 |
0.29 |
| Allergy |
0 |
0.27 |
| Skin Cancer |
0 |
0.27 |
| Skin and Soft Tissue Infection |
0 |
0.26 |
| Food Allergy |
0 |
0.25 |
| Healthcare and Medical Technology |
0 |
0.23 |
| Acne |
0 |
0.22 |
| Immunoglobulin E (IgE) |
0 |
0.22 |
| Clinical Research |
0 |
0.2 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.2 |
| Cutaneous T-Cell Lymphoma |
0 |
0.19 |
| Topical Corticosteroid |
0 |
0.19 |
| Psoriasis |
0 |
0.16 |
| Allergic Contact Dermatitis |
0 |
0.14 |
| Contact Dermatitis |
0 |
0.14 |
| Corticosteroids |
0 |
0.14 |
| Cytokines |
0 |
0.14 |
| Dermatoses |
0 |
0.14 |
| Genetics |
0 |
0.14 |
| Lymphoma |
0 |
0.14 |
| Metabolism |
0 |
0.14 |
| Refractory |
0 |
0.14 |
| Seasonal Allergic Rhinitis |
0 |
0.14 |
| Seborrheic Dermatitis |
0 |
0.14 |
| Sepsis |
0 |
0.14 |
| Toxicology |
0 |
0.13 |
| Genomic Medicine |
0 |
0.12 |
| Eosinophilic Esophagitis |
0 |
0.1 |
| Heart Failure (HF) |
0 |
0.1 |
| Septic Arthritis |
0 |
0.1 |
| Adolescent Medicine |
0 |
0.07 |
| Adverse Effects |
0 |
0.07 |
| Anxiety |
0 |
0.07 |
| Arthritis |
0 |
0.07 |
| Atopy |
0 |
0.07 |
| Autoimmune Disease |
0 |
0.07 |
| Axillary Region |
0 |
0.07 |
| Bacteremia |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Biomedical Technology |
0 |
0.07 |
| Buccal Region |
0 |
0.07 |
| Cardiovascular disease |
0 |
0.07 |
| Cervical Region |
0 |
0.07 |
| Chemokines |
0 |
0.07 |
| Child |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.07 |
| Endocarditis |
0 |
0.07 |
| Erythroderma |
0 |
0.07 |
| Esophagitis |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Face |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Immunoglobulin A (IgA) |
0 |
0.07 |
| Immunology |
0 |
0.07 |
| Inguinal Region |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Keratosis Pilaris |
0 |
0.07 |
| Melasma |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Neuroinflammation |
0 |
0.07 |
| New York |
0 |
0.07 |
| Osteomyelitis |
0 |
0.07 |
| Pollutant |
0 |
0.07 |
| Psychosocial |
0 |
0.07 |
| Rhinitis |
0 |
0.07 |
| Scabies |
0 |
0.07 |
| Scalp |
0 |
0.07 |
| Tissue |
0 |
0.07 |
| Xeroderma |
0 |
0.07 |
| Anxiety Disorder |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Depression |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Microbiome |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Wound Management |
0 |
0.06 |